The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 8893834 |
30 |
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors. |
TBA |
| 20805028 |
32 |
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2. |
University of Toyama |
| 12672241 |
37 |
Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives. |
Università |
| 12238919 |
19 |
A sorbitol dehydrogenase inhibitor of exceptional in vivo potency with a long duration of action: 1-(R)-[4-[4-(4,6-dimethyl[1,3,5]triazin-2-yl)- 2R,6S-dimethylpiperazin-1-yl]pyrimidin-2- yl]ethanol. |
Pfizer |
| 12031323 |
16 |
SAR and species/stereo-selective metabolism of the sorbitol dehydrogenase inhibitor, CP-470,711. |
Pfizer |
| 11784155 |
64 |
Orally-effective, long-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperazino-pyrimidines. |
Pfizer |
| 11720859 |
1 |
Modelling studies of the active site of human sorbitol dehydrogenase: an approach to structure-based inhibitor design of the enzyme. |
Monash University (Parkville Campus) |
| 11495581 |
4 |
Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4-[2-1R-hydroxy-ethyl)-pyrimidin-4-yl]piperazine-1-sulfonic acid dimethylamide. |
Pfizer |
Search and Browse
